AUSTIN, Texas, April 26, 2017 /PRNewswire/ -- Luminex
Corporation (NASDAQ: LMNX) announced today that management will
present at the Deutsche Bank 42nd Annual Health Care Conference on
Wednesday, May 3, 2017 at
10:00am ET in Boston, Massachusetts.
The investor presentation will be webcast live and may be
accessed at Luminex Corporation's website at
http://www.luminexcorp.com. Simply log on to the web at the
address above, go to the Company section and access the Investor
Relations link. Please go to the website at least 15 minutes prior
to the event to register, download and install any necessary
audio/video software. If you are unable to participate during the
live webcast, the presentation will be archived for six months on
the website using the 'replay' link.
ABOUT LUMINEX CORPORATION
At Luminex, our mission is to empower labs to obtain reliable,
timely, and actionable answers, ultimately advancing health.
We offer a wide range of solutions applicable in diverse markets
including clinical diagnostics, pharmaceutical drug discovery,
biomedical research, genomic and proteomic research, biodefense
research, and food safety. We accelerate reliable answers while
simplifying complexity and deliver certainty with a seamless
experience. To learn more about Luminex, please visit us at
www.luminexcorp.com.
|
Contacts:
|
Matt Scalo
|
|
Sr. Director,
Investor Relations
|
|
512-219-8020
|
|
mscalo@luminexcorp.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/luminex-corporation-to-present-at-the-deutsche-bank-42nd-annual-health-care-conference-300445467.html
SOURCE Luminex Corporation